These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1814823)

  • 1. [The effect of gemfibrozil on serum apo C II and C III in diabetic hyperlipidemia].
    Tong N; Liang J
    Hua Xi Yi Ke Da Xue Xue Bao; 1991 Sep; 22(4):409-11. PubMed ID: 1814823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fish oil supplementation versus gemfibrozil treatment in hyperlipidemic NIDDM. A randomized crossover study.
    Fasching P; Rohac M; Liener K; Schneider B; Nowotny P; Waldhäusl W
    Horm Metab Res; 1996 May; 28(5):230-6. PubMed ID: 8738112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical evaluation of simvastatin in the treatment of hyperlipidemia].
    Lu ZL
    Zhonghua Xin Xue Guan Bing Za Zhi; 1993 Aug; 21(4):216-8, 253. PubMed ID: 8194433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postprandial remnant-like lipoproteins in hypertriglyceridemia.
    Ooi TC; Cousins M; Ooi DS; Steiner G; Uffelman KD; Nakajima K; Simo IE
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3134-42. PubMed ID: 11443178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of gemfibrozil on the composition and oxidation properties of very-low-density lipoprotein and high-density lipoprotein in patients with hypertriglyceridemia.
    Hsu HC; Lee YT; Yeh HT; Chen MF
    J Lab Clin Med; 2001 Jun; 137(6):414-21. PubMed ID: 11385362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of gemfibrozil on triglyceride levels in patients with NIDDM. Hyperlipidemia in Diabetes Investigators.
    Vinik AI; Colwell JA
    Diabetes Care; 1993 Jan; 16(1):37-44. PubMed ID: 8422814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effects of Xuezhikang on serum lipid profile, thromboxane A2 and prostacyclin in patients with hyperlipidemia].
    Jian J; Hao X; Deng C; Zhou H; Lin J
    Zhonghua Nei Ke Za Zhi; 1999 Aug; 38(8):517-9. PubMed ID: 11798687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of simultaneous administration of vitamin C and omega-3 fatty acids on lipoproteins, apo A-I, apo B, and malondialdehyde in hyperlipidemic patients.
    Shidfar F; Keshavarz A; Jallali M; Miri R; Eshraghian M
    Int J Vitam Nutr Res; 2003 May; 73(3):163-70. PubMed ID: 12847992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gemfibrozil in the treatment of lipid metabolism disorders].
    Vartanova OA; Aleksandrovskaia TN; Shaldaeva VV
    Klin Med (Mosk); 1994; 72(1):37-41. PubMed ID: 8196321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The abnormal changes of apolipoprotein(s) in patients with type 2 diabetes mellitus].
    Ren Y; Tian H; Liu B; Liang J; Zhang X; Yao J; Xu Y
    Hua Xi Yi Ke Da Xue Xue Bao; 2001 Mar; 32(1):48-51, 69. PubMed ID: 12733353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of serum apolipoprotein C III levels and apolipoprotein C III gene Sst I polymorphism with carotid intima-media thickness in Chinese type 2 diabetic patients.
    Chen X; Tian H; Liu R
    Diabetes Res Clin Pract; 2004 Oct; 66(1):41-7. PubMed ID: 15364160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein C subtype distribution in type 2 diabetes mellitus.
    Gomez JA; del Pozo C; Sorribas A; Serrat J; Gonzalez-Sastre F; de Leiva A
    Diabet Med; 1989 Mar; 6(2):127-30. PubMed ID: 2522853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
    Attman PO; Samuelsson OG; Moberly J; Johansson AC; Ljungman S; Weiss LG; Knight-Gibson C; Alaupovic P
    Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of gemfibrozil on serum levels of prostacyclin and precursor fatty acids in hyperlipidemic patients with Type 2 diabetes.
    Yoshinari M; Asano T; Kaori S; Shi AH; Wakisaka M; Iwase M; Fujishima M
    Diabetes Res Clin Pract; 1998 Dec; 42(3):149-54. PubMed ID: 9925344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of gemfibrozil treatment in sulfonylurea-treated patients with noninsulin-dependent diabetes mellitus.
    Shen DC; Fuh MM; Shieh SM; Chen YD; Reaven GM
    J Clin Endocrinol Metab; 1991 Sep; 73(3):503-10. PubMed ID: 1874929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Gemfibrozil in the treatment of hyperlipidemia].
    Wang JJ; Song YM; Wang YS; Lin WH
    Zhonghua Yi Xue Za Zhi (Taipei); 1989 Feb; 43(2):131-4. PubMed ID: 2766068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence of Apo B48, and relative Apo CII deficiency and Apo CIII enrichment in uremic very-low density lipoproteins.
    Atger V; Beyne P; Frommherz K; Roullet JB; Drüeke T
    Ann Biol Clin (Paris); 1989; 47(8):497-501. PubMed ID: 2690681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of nicotinic acid on concentrations of serum apolipoproteins B, C-I, C-II, C-III and E in hyperlipidemic patients.
    Wahlberg G; Holmquist L; Walldius G; Annuzzi G
    Acta Med Scand; 1988; 224(4):319-27. PubMed ID: 3188982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Gender differences and diabetic status in the relationship of blood apolipoprotein C-III, free fatty acids and triglycerides in subjects at risk for glucose intolerance].
    Flórez H; Méndez AJ; Jones L; Goldberg RB
    Invest Clin; 1999 Mar; 40(1):51-66. PubMed ID: 10198561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gemfibrozil treatment increases low-density lipoprotein particle size in Type 2 diabetes mellitus but does not alter in vitro oxidizability.
    O'Neal DN; O'Brien RC; Timmins KL; Grieve GD; Lau KP; Nicholson GC; Kotowicz MA; Best JD
    Diabet Med; 1998 Oct; 15(10):870-7. PubMed ID: 9796889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.